Advertisement

Topics

Companies Related to "Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure" [Most Relevant Company Matches] - Page: 3 RSS

13:17 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Efficacy Atrasentan With Hormone Naive Prostate Cancer" Companies 51–75 of 4,000+

Relevant

America's Leading Prostate Cancer Organizations


The Georgia Prostate Cancer Pledge Committee

NanOlogy, LLC

NanOlogy, LLC (www.nanology.us) is a company formed by DFB Pharmaceuticals, LLC of Fort Worth, TX, CritiTech, Inc. of Lawrence, KS, and US Biotest, Inc. of San Luis Obispo, CA, to finance and clinically develop a patented nanoparticle technology platform for local, sustained delivery of proven drugs aimed at increasing their safety and efficacy in the trea...


NanOlogy LLC

NanOlogy, LLC (www.nanology.us) is a company formed by DFB Pharmaceuticals, LLC of Fort Worth, TX, CritiTech, Inc. of Lawrence, KS, and US Biotest, Inc. of San Luis Obispo, CA, to finance and clinically develop a patented nanoparticle technology platform for local, sustained delivery of proven drugs aimed at increasing their safety and efficacy in t...

Gamma Labs

Gamma Labs, a division of Gamma Enterprises, LLC, is a company dedicated to supplying its customers with natural supplements which are based on the latest science and manufactured to the highest levels of pharmaceutical standards. Founded in 2004, Gamma Labs’ mission is to deliver proven, natural supplements which set up a foundation for peak performa...

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology investigates biomarkers at the structural level as opposed to overall concentration, giving better insights as to its cellular origin. Its pipeline of high performance, non-invasive ca...

Aragon Pharmaceuticals Inc.

Aragon Pharmaceuticals is a privately held small-molecule drug discovery company identifying breakthrough medicines for the treatment of hormonally driven cancers. These cancers are traditionally treated with anti-hormonal therapies but often become resistant, and follow-on therapies are largely ineffective. The company plans to initiate a clinical trial with its lead compound, ARN-509, in patient...

European Randomized Study of Screening for Prostate Cancer (ERSPC)

ERSPC (European Randomized Study of Screening for Prostate Cancer)

Progenics Pharmaceuticals

Progenics Pharmaceuticals, Inc., of Tarrytown, NY, is a biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Principal programs are directed toward gastroenterology as well as the treatment of HIV infection and cancer. The Company has fo...

Henry Ford Hospital

Henry Ford Hospital, a 802-bed tertiary care hospital, education and research complex in Detroit’s New Center Area, is the flagship hospital for Henry Ford Health System. The Henry Ford Vattikuti Urology Institute is the leading prostate cancer program in the world where patients have access to the some of the most innovative technology and treatment ...

Signet Laboratories Incorporated

Signet Laboratories, Inc is a medical biotechnology company focused in fields of cancer and infectious disease(Sepsis). Signet has developed proprietary antibody systems for the detection and management of breast and prostate cancer and Sepsis. Signet's patented technology will provide for determining risk in "normal patients who may be at increased risk for developing cancer at a time when proac...

Medivation, Inc.

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation announced a global agreement with Pfizer, Inc to develop an...

Sonus Pharmaceuticals, Inc.

Headquartered near Seattle, Washington, Sonus Pharmaceuticals, Inc. is focused on the development of cancer drugs that are designed to provide better efficacy, safety and tolerability, and ease of use. Sonus moved an oncology product candidate, SN2310, into a Phase 1 clinical trial in September 2006. For additional information on Sonus, including past news releases, please visit http://www.son...

Cytogen

Cytogen is a specialty pharmaceutical company dedicated to advancing the treatment and care of cancer patients by building, developing, and commercializing a portfolio of oncology products. The Company's specialized sales force currently markets QUADRAMET® (samarium Sm-153 lexidronam injection), PROSTASCINT® (capromab pendetide), and SOLTAMOX™ (tamoxifen citrate) to the U.S. oncology market. Q...

Jennerex Biotherapeutics

Jennerex is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594, currently in an international randomized Phase 2 clinical trial for patients with primary liver cancer, demonstrated promising Phase 1 efficacy and safety results in patients with a diverse a...

Quintiles Scotland

Safety PharmacologyQuintiles has safety pharmacology services to identify the potential adverse pharmacological effects of new chemical entities prior to first administration to man. Regulatory Safety Pharmacology packages Haemodynamics/ECG studies Cardiac action potential in vitro QT prolongationIon channels (e.g. HERG) Discovery SupportQuintiles pharmacologists can provide support in defining th...

Tokai Pharmaceuticals, Inc.

Tokai Pharmaceuticals is a U.S. biopharmaceutical company focused on developing new treatments for prostate cancer. The company’s lead drug candidate, galeterone (TOK-001), is the first investigational new drug that can decrease overall androgen receptor levels in prostate tumors and in which three distinct mechanisms of action are combined in one onc...

CarrollDrugs.Com - The online department of Taneytown Pharmacy

Carroll Drugs offers full line pharmacy services and features hormone replacement therapy with local and national delivery. In addition to traditional prescriptions, we compound medications specific to each patient by order of a physician, such as hormone replacement therapy. E-mail or call us us to find out about our VERY reasonable prices on drugs and compounds like bio-identical hormone replac...

Accelsiors

Accelsiors is a scientifically-driven CRO committed to serving the needs of its Sponsors with the highest level of quality. We provide a full array of services and pride ourselves on having ready access to treatment naive patient populations. From consulting with you on the optimal design of your protocol to providing a final CSR, and all services in betwe...

CLINICAL RESEARCH LABORATORIES, INC

Clinical Research Laboratories, Inc. (CRL) was incorporated in 1992. Today, CRL operates as an independent contract laboratory providing a wide range of clinical safety and efficacy testing to the cosmetic and pharmaceutical industries. Located in central New Jersey, CRL is dedicated to conducting human clinical test procedures to determine the safety and efficacy of cosmetic, personal care, and O...

John Wayne Cancer Institute Auxiliary

Since 1981, the family of John Wayne has been committed to pioneering cancer research in memory of their father, who died of cancer. For more than 30 years, the dedicated physicians and scientists at the John Wayne Cancer Institute (JWCI) have made groundbreaking discoveries that have changed the way cancer is detected, diagnosed and treated around the wor...

Update Pharma Inc.

Update Pharma Inc. is developing UPI-928, an agent developed in the 1980’s by Lederle Laboratories in 44 phase 1, 2 and 3 clinical trials, including 33 clinical trials at the National Cancer Institute. Despite an acceptable safety database of over 2,000 treated patients, over 70 peer reviewed clinical publications that demonstrated efficacy in leukemi...

AlphaVax, Inc

AlphaVax is developing a new vaccine technology with broad applications against infectious disease, cancer and biodefense threats which has the potential to redefine vaccines and the role they play in medicine. AlphaVax uses a specialized viral vector system to make alphavirus replicon vaccines called alphavaccines, which have shown excellent protection in multiple models for infectious disease an...

Nucletron B.V.

Nucletron is a radiotherapy company that specializes in the development, manufacture, sales, service and support of the world's most innovative products for cancer treatment. As a company, our guiding principle is the customer's demand for quality, safety and reliability. We continuously invest in innovative research and development. This approach has made it possible to successfully treat cancers...


More From BioPortfolio on "Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks